Selected Financial Data
since 2005
Income Statement
Vertex Pharmaceuticals Inc., selected items from income statement, long-term trends
US$ in thousands
| 12 months ended: | Revenues | Income (loss) from operations | Net income (loss) |
|---|---|---|---|
| Dec 31, 2023 | 9,869,200) | 3,832,000) | 3,619,600) |
| Dec 31, 2022 | 8,930,700) | 4,307,400) | 3,322,000) |
| Dec 31, 2021 | 7,574,400) | 2,782,100) | 2,342,100) |
| Dec 31, 2020 | 6,205,683) | 2,856,290) | 2,711,647) |
| Dec 31, 2019 | 4,162,821) | 1,197,566) | 1,176,810) |
| Dec 31, 2018 | 3,047,597) | 635,150) | 2,096,896) |
| Dec 31, 2017 | 2,488,652) | 123,243) | 263,484) |
| Dec 31, 2016 | 1,702,177) | 9,936) | (112,052) |
| Dec 31, 2015 | 1,032,336) | (466,879) | (556,334) |
| Dec 31, 2014 | 580,415) | (692,412) | (738,555) |
| Dec 31, 2013 | 1,211,975) | (903,448) | (445,028) |
| Dec 31, 2012 | 1,527,042) | 2,332) | (107,032) |
| Dec 31, 2011 | 1,410,626) | 113,820) | 29,574) |
| Dec 31, 2010 | 143,370) | (696,077) | (754,626) |
| Dec 31, 2009 | 101,889) | (614,012) | (642,178) |
| Dec 31, 2008 | 175,504) | (462,708) | (459,851) |
| Dec 31, 2007 | 199,012) | (419,792) | (391,279) |
| Dec 31, 2006 | 216,356) | (229,038) | (206,891) |
| Dec 31, 2005 | 160,890) | (149,872) | (203,417) |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Balance Sheet: Assets
Vertex Pharmaceuticals Inc., selected items from assets, long-term trends
US$ in thousands
| Current assets | Total assets | |
|---|---|---|
| Dec 31, 2023 | 14,144,200) | 22,730,200) |
| Dec 31, 2022 | 13,234,800) | 18,150,900) |
| Dec 31, 2021 | 9,560,600) | 13,432,500) |
| Dec 31, 2020 | 8,133,379) | 11,751,808) |
| Dec 31, 2019 | 4,822,829) | 8,318,465) |
| Dec 31, 2018 | 3,843,109) | 6,245,898) |
| Dec 31, 2017 | 2,648,963) | 3,546,014) |
| Dec 31, 2016 | 1,831,540) | 2,896,787) |
| Dec 31, 2015 | 1,407,153) | 2,498,875) |
| Dec 31, 2014 | 1,546,511) | 2,334,679) |
| Dec 31, 2013 | 1,588,576) | 2,319,041) |
| Dec 31, 2012 | 1,589,585) | 2,759,288) |
| Dec 31, 2011 | 1,331,254) | 2,204,280) |
| Dec 31, 2010 | 1,057,039) | 1,725,446) |
| Dec 31, 2009 | 1,307,026) | 1,955,488) |
| Dec 31, 2008 | 867,581) | 980,479) |
| Dec 31, 2007 | 496,851) | 601,477) |
| Dec 31, 2006 | 771,406) | 921,579) |
| Dec 31, 2005 | 385,055) | 548,998) |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Balance Sheet: Liabilities and Stockholders’ Equity
Vertex Pharmaceuticals Inc., selected items from liabilities and stockholders’ equity, long-term trends
US$ in thousands
| Current liabilities | Total liabilities | Total long-term obligations | Shareholders’ equity | |
|---|---|---|---|---|
| Dec 31, 2023 | 3,547,400) | 5,149,800) | 426,700) | 17,580,400) |
| Dec 31, 2022 | 2,742,100) | 4,238,200) | 471,600) | 13,912,700) |
| Dec 31, 2021 | 2,142,000) | 3,332,500) | 556,700) | 10,100,000) |
| Dec 31, 2020 | 1,877,533) | 3,064,993) | 581,476) | 8,686,815) |
| Dec 31, 2019 | 1,334,827) | 2,233,221) | 568,869) | 6,085,244) |
| Dec 31, 2018 | 1,120,292) | 1,810,695) | 586,821) | 4,435,203) |
| Dec 31, 2017 | 807,260) | 1,503,708) | 583,902) | 2,028,579) |
| Dec 31, 2016 | 792,537) | 1,558,596) | 821,335) | 1,156,582) |
| Dec 31, 2015 | 506,349) | 1,405,247) | 810,981) | 939,967) |
| Dec 31, 2014 | 368,254) | 1,238,496) | 807,141) | 1,075,006) |
| Dec 31, 2013 | 397,829) | 962,636) | 489,691) | 1,356,405) |
| Dec 31, 2012 | 432,624) | 1,524,906) | 683,201) | 999,180) |
| Dec 31, 2011 | 392,348) | 1,238,768) | 455,950) | 786,843) |
| Dec 31, 2010 | 474,783) | 1,221,473) | 536,991) | 503,973) |
| Dec 31, 2009 | 284,883) | 859,142) | 153,836) | 1,096,346) |
| Dec 31, 2008 | 216,564) | 741,605) | 287,500) | 238,874) |
| Dec 31, 2007 | 199,279) | 330,182) | 19,997) | 271,295) |
| Dec 31, 2006 | 251,014) | 415,644) | 121,747) | 505,935) |
| Dec 31, 2005 | 100,243) | 309,822) | 180,097) | 239,176) |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Cash Flow Statement
Vertex Pharmaceuticals Inc., selected items from cash flow statement, long-term trends
US$ in thousands
| 12 months ended: | Net cash provided by (used in) operating activities | Net cash (used in) provided by investing activities | Net cash provided by (used in) financing activities |
|---|---|---|---|
| Dec 31, 2023 | 3,537,300) | (3,141,700) | (562,200) |
| Dec 31, 2022 | 4,129,900) | (321,100) | (67,700) |
| Dec 31, 2021 | 2,643,500) | (340,900) | (1,478,000) |
| Dec 31, 2020 | 3,253,505) | 99,388) | (505,281) |
| Dec 31, 2019 | 1,569,330) | (1,235,318) | 126,773) |
| Dec 31, 2018 | 1,270,286) | (202,158) | (71,219) |
| Dec 31, 2017 | 844,942) | (437,681) | 68,404) |
| Dec 31, 2016 | 236,103) | 104,469) | 133,271) |
| Dec 31, 2015 | (365,432) | 268,856) | 188,919) |
| Dec 31, 2014 | (513,199) | 73,959) | 497,376) |
| Dec 31, 2013 | (51,570) | (54,130) | 180,884) |
| Dec 31, 2012 | 267,841) | (425,817) | 172,204) |
| Dec 31, 2011 | 143,735) | 212,412) | (124,238) |
| Dec 31, 2010 | (635,442) | 7,301) | 425,057) |
| Dec 31, 2009 | (427,586) | (508,732) | 999,006) |
| Dec 31, 2008 | (226,482) | (360,650) | 620,738) |
| Dec 31, 2007 | (252,476) | 405,166) | (10,190) |
| Dec 31, 2006 | (22,475) | (208,471) | 365,865) |
| Dec 31, 2005 | (172,054) | (1,732) | 197,456) |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Per Share Data
Vertex Pharmaceuticals Inc., selected data per share, long-term trends
US$
| 12 months ended: | Basic earnings per share 1 | Diluted earnings per share 2 | Dividend per share 3 |
|---|---|---|---|
| Dec 31, 2023 | 14.05 | 13.89 | 0.00 |
| Dec 31, 2022 | 12.97 | 12.82 | 0.00 |
| Dec 31, 2021 | 9.09 | 9.01 | 0.00 |
| Dec 31, 2020 | 10.44 | 10.29 | 0.00 |
| Dec 31, 2019 | 4.58 | 4.51 | 0.00 |
| Dec 31, 2018 | 8.24 | 8.09 | 0.00 |
| Dec 31, 2017 | 1.06 | 1.04 | 0.00 |
| Dec 31, 2016 | -0.46 | -0.46 | 0.00 |
| Dec 31, 2015 | -2.31 | -2.31 | 0.00 |
| Dec 31, 2014 | -3.14 | -3.14 | 0.00 |
| Dec 31, 2013 | -1.98 | -1.98 | 0.00 |
| Dec 31, 2012 | -0.50 | -0.50 | 0.00 |
| Dec 31, 2011 | 0.14 | 0.14 | 0.00 |
| Dec 31, 2010 | -3.77 | -3.77 | 0.00 |
| Dec 31, 2009 | -3.71 | -3.71 | 0.00 |
| Dec 31, 2008 | -3.27 | -3.27 | 0.00 |
| Dec 31, 2007 | -3.03 | -3.03 | 0.00 |
| Dec 31, 2006 | -1.83 | -1.83 | 0.00 |
| Dec 31, 2005 | -2.28 | -2.28 | 0.00 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1, 2, 3 Data adjusted for splits and stock dividends.